D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CADL holding history

Candel Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CADL overview All 13F holders of CADL Full Q2 2026 holdings

Shares (Q2 2026): 108,933
Value: $1.12M
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2021

Holdings of CADL by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	108,933	$1.12M	<0.1%	+108,933	New	Holders
Q2 2022	0	$0	0.0%	−10,867−100.0%	Sold out	Holders
Q1 2022	10,867	$55.0K	<0.1%	+745+7.4%	Added	Holders
Q4 2021	10,122	$79.0K	<0.1%	+10,122	New	Holders